LONDON–(BUSINESS WIRE)–#GlobalPediatricMedicinesMarket–Technavio has been monitoring the pediatric medicines market and it is poised to grow by USD 27.71 billion during 2020-2024, progressing at a CAGR of about 5% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Please Request Free Sample Report on COVID-19 Impact
The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. AbbVie Inc., Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi, and Takeda Pharmaceutical Co. Ltd. are some of the major market participants. Formulatory advancement will offer immense growth opportunities. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
Formulatory advancement has been instrumental in driving the growth of the market. (Read more…)
Pediatric Medicines Market 2020-2024: Segmentation
Pediatric Medicines Market is segmented as below:
-
Type
- Respiratory Diseases
- Infectious Diseases
- Gastrointestinal Diseases
- CNS Diseases
- Oncological Diseases
- Others
-
Geographic Landscape
- Asia
- Europe
- North America
- ROW
-
RoA
- Enteral
- Parenteral
- Topical
To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR43146
Pediatric Medicines Market 2020-2024: Scope
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our pediatric medicines market report covers the following areas:
- Pediatric Medicines Market Size
- Pediatric Medicines Market Trends
- Pediatric Medicines Market Industry Analysis
This study identifies inorganic growth strategies as one of the prime reasons driving the pediatric medicines market growth during the next few years.
Pediatric Medicines Market 2020-2024: Vendor Analysis
We provide a detailed analysis of vendors operating in the pediatric medicines market, including some of the vendors such as AbbVie Inc., Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi, and Takeda Pharmaceutical Co. Ltd. Backed with competitive intelligence and benchmarking, our research reports on the pediatric medicines market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio’s SUBSCRIPTION platform
Pediatric Medicines Market 2020-2024: Key Highlights
- CAGR of the market during the forecast period 2020-2024
- Detailed information on factors that will assist pediatric medicines market growth during the next five years
- Estimation of the pediatric medicines market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the pediatric medicines market
- Analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of pediatric medicines market vendors
Table Of Contents:
Executive Summary
- Market Overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 – 2024
Five Forces Analysis
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by End-user
- Market segments
- Comparison by End user
- Energy – Market size and forecast 2019-2024
- Manufacturing – Market size and forecast 2019-2024
- Others – Market size and forecast 2019-2024
- Market opportunity by End user
Customer landscape
- Overview
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America – Market size and forecast 2019-2024
- Europe – Market size and forecast 2019-2024
- APAC – Market size and forecast 2019-2024
- MEA – Market size and forecast 2019-2024
- South America – Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
Drivers, Challenges, and Trends
- Market drivers
- Volume driver – Demand led growth
- Volume driver – Supply led growth
- Volume driver – External factors
- Volume driver – Demand shift in adjacent markets
- Price driver – Inflation
- Price driver – Shift from lower to higher priced units
- Market challenges
- Market trends
Vendor Landscape
- Overview
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Aqualyng ICES
- AVANTech Inc.
- Evoqua Water Technologies LLC
- Fluence Corp. Ltd.
- MWG Srl
- National Oilwell Varco Inc.
- Orenco Systems Inc.
- Pall Corp.
- SUEZ WTS USA Inc.
- Veolia Environnement SA
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/